FULCRUM THERAPEUTICS INC (FULC)
US3596161097 - Common Stock
ChartMill assigns a Buy % Consensus number of 73% to FULC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.39. This target is 65.13% above the current price.
FULC was analyzed by 14 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about FULC.
In the previous month the buy percentage consensus was at a similar level.
FULC was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-09-13 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2024-09-13 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-09-12 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2024-09-12 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2024-09-12 | Stifel | Downgrade | Buy -> Hold |
| 2024-09-12 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2024-09-09 | B of A Securities | Upgrade | Underperform -> Neutral |
| 2024-08-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-10 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-05-20 | Cantor Fitzgerald | Initiate | Overweight |
| 2024-05-14 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-05-14 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2024-05-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-13 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2024-03-13 | RBC Capital | Initiate | Outperform |
| 2024-02-28 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-02-28 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-01-26 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-01-25 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-09-25 | Goldman Sachs | Initiate | Neutral |
| 2023-08-23 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2023-08-22 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2023-08-22 | Stifel | Upgrade | Hold -> Buy |
| 2023-08-04 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2023-05-16 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-05-16 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2023-05-05 | Goldman Sachs | Maintains | Neutral |
| 2023-05-04 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2023-03-13 | Goldman Sachs | Maintains | Buy |
| 2023-03-10 | Credit Suisse | Downgrade | Outperform -> Neutral |